Annual report pursuant to Section 13 and 15(d)

GOODWILL - Impairment Testing (Details)

v3.22.1
GOODWILL - Impairment Testing (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2021
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Goodwill [Line Items]          
Goodwill impairment     $ 18,508,000 $ 1,682,000  
Goodwill $ 0   $ 0 18,508,000 $ 20,190,000
Discounted Future Cash Flow          
Goodwill [Line Items]          
Impairment analysis, weighted-average cost of capital 14.00% 19.00% 14.00%    
Impairment analysis, perpetual growth rate 3.00% 2.00%      
Non-Cannabinoid          
Goodwill [Line Items]          
Goodwill impairment   $ 1,682,000 $ 0 1,682,000  
Goodwill $ 0 $ 0 $ 0 $ 0 $ 1,682,000